These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 25642595)

  • 1. Predicted structures for kappa opioid G-protein coupled receptor bound to selective agonists.
    Li Q; Kim SK; Goddard WA; Chen G; Tan H
    J Chem Inf Model; 2015 Mar; 55(3):614-27. PubMed ID: 25642595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The predicted ensemble of low-energy conformations of human somatostatin receptor subtype 5 and the binding of antagonists.
    Dong SS; Abrol R; Goddard WA
    ChemMedChem; 2015 Apr; 10(4):650-61. PubMed ID: 25772628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular modeling on kappa opioid receptor and its interaction with nonpeptide kappa opioid agonists.
    Liu DX; Jiang HL; Shen JS; Zhu WL; Zhao L; Chen KX; Ji RY
    Zhongguo Yao Li Xue Bao; 1999 Feb; 20(2):131-6. PubMed ID: 10437159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conformational analysis and automated receptor docking of selective arylacetamide-based kappa-opioid agonists.
    Subramanian G; Paterlini MG; Larson DL; Portoghese PS; Ferguson DM
    J Med Chem; 1998 Nov; 41(24):4777-89. PubMed ID: 9822548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discriminative stimulus effects of mu and kappa opioids in the pigeon: analysis of the effects of full and partial mu and kappa agonists.
    Picker MJ; Dykstra LA
    J Pharmacol Exp Ther; 1989 May; 249(2):557-66. PubMed ID: 2566680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of the cloned human kappa opioid receptor by agonists enhances [35S]GTPgammaS binding to membranes: determination of potencies and efficacies of ligands.
    Zhu J; Luo LY; Li JG; Chen C; Liu-Chen LY
    J Pharmacol Exp Ther; 1997 Aug; 282(2):676-84. PubMed ID: 9262330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discriminative stimulus properties of U50,488 and morphine: effects of training dose on stimulus substitution patterns produced by mu and kappa opioid agonists.
    Picker MJ; Doty P; Negus SS; Mattox SR; Dykstra LA
    J Pharmacol Exp Ther; 1990 Jul; 254(1):13-22. PubMed ID: 2164087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemotype-selective modes of action of κ-opioid receptor agonists.
    Vardy E; Mosier PD; Frankowski KJ; Wu H; Katritch V; Westkaemper RB; Aubé J; Stevens RC; Roth BL
    J Biol Chem; 2013 Nov; 288(48):34470-83. PubMed ID: 24121503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Homology models of mu-opioid receptor with organic and inorganic cations at conserved aspartates in the second and third transmembrane domains.
    Zhorov BS; Ananthanarayanan VS
    Arch Biochem Biophys; 2000 Mar; 375(1):31-49. PubMed ID: 10683246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative modeling of human kappa opioid receptor and docking analysis with the peptide YFa.
    Patra MC; Kumar K; Pasha S; Chopra M
    J Mol Graph Model; 2012 Mar; 33():44-51. PubMed ID: 22172315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ligand/kappa-opioid receptor interactions: insights from the X-ray crystal structure.
    Martinez-Mayorga K; Byler KG; Yongye AB; Giulianotti MA; Dooley CT; Houghten RA
    Eur J Med Chem; 2013 Aug; 66():114-21. PubMed ID: 23792349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discriminative stimulus effects of opioids in pigeons trained to discriminate fentanyl, bremazocine and water: evidence of pharmacological selectivity.
    Picker MJ; Cook CD
    Behav Pharmacol; 1997 Jun; 8(2-3):160-73. PubMed ID: 9833011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The 3D Structure of Human DP Prostaglandin G-Protein-Coupled Receptor Bound to Cyclopentanoindole Antagonist, Predicted Using the DuplexBiHelix Modification of the GEnSeMBLE Method.
    Shankar V; Goddard WA; Kim SK; Abrol R; Liu F
    J Chem Theory Comput; 2018 Mar; 14(3):1624-1642. PubMed ID: 29268008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Establishment of kappa opioid receptor agonists pharmacophore with molecular modeling method.
    Liu DX; Tang Y; Jiang HL; Chen KX; Ji RY
    Zhongguo Yao Li Xue Bao; 1998 Sep; 19(5):445-50. PubMed ID: 10375807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improving virtual screening of G protein-coupled receptors via ligand-directed modeling.
    Coudrat T; Simms J; Christopoulos A; Wootten D; Sexton PM
    PLoS Comput Biol; 2017 Nov; 13(11):e1005819. PubMed ID: 29131821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A subset of kappa opioid ligands bind to the membrane glucocorticoid receptor in an amphibian brain.
    Evans SJ; Searcy BT; Moore FL
    Endocrinology; 2000 Jul; 141(7):2294-300. PubMed ID: 10875228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identifying Functional Hotspot Residues for Biased Ligand Design in G-Protein-Coupled Receptors.
    Nivedha AK; Tautermann CS; Bhattacharya S; Lee S; Casarosa P; Kollak I; Kiechle T; Vaidehi N
    Mol Pharmacol; 2018 Apr; 93(4):288-296. PubMed ID: 29367258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New insights from structural biology into the druggability of G protein-coupled receptors.
    Mason JS; Bortolato A; Congreve M; Marshall FH
    Trends Pharmacol Sci; 2012 May; 33(5):249-60. PubMed ID: 22465153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discriminative stimulus properties of nalorphine in the rhesus monkeys.
    Tang AH; Code RA
    J Pharmacol Exp Ther; 1983 Dec; 227(3):563-9. PubMed ID: 6317838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A kappa opioid effect: increased urination in the rat.
    Leander JD
    J Pharmacol Exp Ther; 1983 Jan; 224(1):89-94. PubMed ID: 6294284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.